These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 35763196)

  • 21. Adaptation of the in vitro micronucleus assay for genotoxicity testing using 3D liver models supporting longer-term exposure durations.
    Conway GE; Shah UK; Llewellyn S; Cervena T; Evans SJ; Al Ali AS; Jenkins GJ; Clift MJD; Doak SH
    Mutagenesis; 2020 Sep; 35(4):319-330. PubMed ID: 32780103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypic Characterization of Toxic Compound Effects on Liver Spheroids Derived from iPSC Using Confocal Imaging and Three-Dimensional Image Analysis.
    Sirenko O; Hancock MK; Hesley J; Hong D; Cohen A; Gentry J; Carlson CB; Mann DA
    Assay Drug Dev Technol; 2016 Sep; 14(7):381-94. PubMed ID: 27494736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three-Dimensional Spheroids for Cancer Research.
    Tutty MA; Prina-Mello A
    Methods Mol Biol; 2023; 2645():65-103. PubMed ID: 37202612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-throughput confocal imaging of differentiated 3D liver-like spheroid cellular stress response reporters for identification of drug-induced liver injury liability.
    Hiemstra S; Ramaiahgari SC; Wink S; Callegaro G; Coonen M; Meerman J; Jennen D; van den Nieuwendijk K; Dankers A; Snoeys J; de Bont H; Price L; van de Water B
    Arch Toxicol; 2019 Oct; 93(10):2895-2911. PubMed ID: 31552476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AlgiMatrix™-Based 3D Cell Culture System as an In Vitro Tumor Model: An Important Tool in Cancer Research.
    Godugu C; Singh M
    Methods Mol Biol; 2016; 1379():117-28. PubMed ID: 26608295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of in vitro 3D cell model from hepatocellular carcinoma (HepG2) cell line and its application for genotoxicity testing.
    Štampar M; Tomc J; Filipič M; Žegura B
    Arch Toxicol; 2019 Nov; 93(11):3321-3333. PubMed ID: 31542801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ready to go 3D? A semi-automated protocol for microwell spheroid arrays to increase scalability and throughput of 3D cell culture testing.
    Basu A; Dydowiczová A; Trosko JE; Bláha L; Babica P
    Toxicol Mech Methods; 2020 Oct; 30(8):590-604. PubMed ID: 32713235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-Dimensional Liver Culture Systems to Maintain Primary Hepatic Properties for Toxicological Analysis In Vitro.
    Kammerer S
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.
    Kessel S; Cribbes S; Bonasu S; Rice W; Qiu J; Chan LL
    Cytometry A; 2017 Sep; 91(9):883-892. PubMed ID: 28618188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel evaluation method for determining drug-induced hepatotoxicity using 3D bio-printed human liver tissue.
    Ide I; Nagao E; Kajiyama S; Mizoguchi N
    Toxicol Mech Methods; 2020 Mar; 30(3):189-196. PubMed ID: 31736396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell Viability Assays in Three-Dimensional Hydrogels: A Comparative Study of Accuracy.
    Dominijanni AJ; Devarasetty M; Forsythe SD; Votanopoulos KI; Soker S
    Tissue Eng Part C Methods; 2021 Jul; 27(7):401-410. PubMed ID: 34082602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of Drug-Induced Hepatotoxicity Using Long-Term Stable Primary Hepatic 3D Spheroid Cultures in Chemically Defined Conditions.
    Vorrink SU; Zhou Y; Ingelman-Sundberg M; Lauschke VM
    Toxicol Sci; 2018 Jun; 163(2):655-665. PubMed ID: 29590495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AlgiMatrix™ based 3D cell culture system as an in-vitro tumor model for anticancer studies.
    Godugu C; Patel AR; Desai U; Andey T; Sams A; Singh M
    PLoS One; 2013; 8(1):e53708. PubMed ID: 23349734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metal-Organic Framework Mediated Radio-Enhancement Assessed in High-Throughput-Compatible 3D Tumor Spheroid Co-Cultures.
    Neuer AL; Vogel A; Gogos A; Kissling VM; Tsolaki E; Herrmann IK
    Adv Biol (Weinh); 2023 Jul; 7(7):e2300075. PubMed ID: 37178330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HepG2 (C3A) spheroids show higher sensitivity compared to HepaRG spheroids for drug-induced liver injury (DILI).
    Basharat A; Rollison HE; Williams DP; Ivanov DP
    Toxicol Appl Pharmacol; 2020 Dec; 408():115279. PubMed ID: 33068618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3D organotypic cultures of human HepaRG cells: a tool for in vitro toxicity studies.
    Gunness P; Mueller D; Shevchenko V; Heinzle E; Ingelman-Sundberg M; Noor F
    Toxicol Sci; 2013 May; 133(1):67-78. PubMed ID: 23377618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-Analysis of Pharmacokinetic Studies of Nanobiomaterials for the Prediction of Excretion Depending on Particle Characteristics.
    Hauser M; Nowack B
    Front Bioeng Biotechnol; 2019; 7():405. PubMed ID: 31921810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrasmall gold nanoparticles (2 nm) can penetrate and enter cell nuclei in an in vitro 3D brain spheroid model.
    Sokolova V; Nzou G; van der Meer SB; Ruks T; Heggen M; Loza K; Hagemann N; Murke F; Giebel B; Hermann DM; Atala AJ; Epple M
    Acta Biomater; 2020 Jul; 111():349-362. PubMed ID: 32413579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of 3D-aggregated spheroid model (3D-ASM) for selecting high efficacy drugs.
    Lee SY; Hwang HJ; Lee DW
    Sci Rep; 2022 Nov; 12(1):18937. PubMed ID: 36344810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances.
    Minnema J; Borgos SEF; Liptrott N; Vandebriel R; Delmaar C
    Drug Deliv Transl Res; 2022 Sep; 12(9):2132-2144. PubMed ID: 35551616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.